… that exenatide consistently reduced UACR compared to … native GLP-1 (either human GLP-1
or exendin-4) and GLP-1 … characterizing experimental diabetic nephropathy, irrespective of …

… , a glucagon-like peptide-1 (GLP-1) analogue. These … of diabetic patients suffer from diabetic
nephropathy particularly … ADMSCs or exenatide treatment compared to diabetic groups. …

… on early diabetic nephropathy without notable differences … Exenatide (EXE) is a GLP-1
analogue and non degradable by … conducted to examine the effect of exenatide, a GLP-1 receptor …

… Exenatide is a glucagon-like peptide-1 (GLP-1) receptor … weight loss compared with
metformin-treated and exenatide-treated (… )-nicotinamide-induced diabetic nephropathy treated …

… exenatide solution and exenatide-loaded polymers and, compared with the Control group,
we found that diabetic male … GLP-1 receptor agonist that shares 82% homology with human …

… the effect of exenatide (EXE), a glucagon-like peptide (GLP)-1 … , is closely associated with
diabetic nephropathy (DN), a … (UACR)-lowering effect of exenatide compared to the comparator …

… diabetic nephropathy without decrease in blood glucose levels. In the study, AH seeds showed
beneficial effects … find any differences between the diabetes group and the diabetes + AH …

… In experimental models of diabetic nephropathy and non-diabetic renal injury, GLP-1 analogues
and … Natriuretic effect of exenatide: high efficacy and site of action. Eksperimental’naya i …

… ) in relation to kidney deterioration as compared with group A (… In the pancreas GLP-1R was
controlled glycaemia by stimulate … Effect of serum cystatin C in early diabetic nephropathy in …

… Analogs of the GLP-1R (such as oxyntomodulin and exenatide) promote synaptogenesis, …
The structure of vasopressin, a similar nonapeptide with only two amino acid differences from …